SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of March 2005 (March 8, 2005)
Commission File Number: 0-15850
ANSELL LIMITED
(Translation of registrants name into English)
Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
This Form 6-K contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended, and information that is based on managements beliefs as well as assumptions made by and information currently available to management. When used in this Form 6-K, the words anticipate, approach, begin, believe, continue, expect, forecast, going forward, improved, likely, look forward, opportunity, outlook, plans, potential, proposal, should and would and similar expressions are intended to identify forward-looking statements. These forward-looking statements necessarily make assumptions, some of which are inherently subject to uncertainties and contingencies that are beyond the Companys control. Should one or more of these uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated or projected. Specifically, the ability of the Company to realize its ongoing commitment to increasing shareholder value through its ongoing restructuring, asset dispositions, strategic review and implementation, and cost cutting initiatives, may be affected by many factors including: uncertainties and contingencies such as economic conditions both in the world and in those areas where the Company has or will have substantial operations; foreign currency exchange rates; pricing pressures on products produced by its subsidiaries; growth prospects; positioning of its business segments; future productions output capacity; and the success of the Companys business strategies, including further structural and operational changes, business dispositions, internal reorganizations, cost cutting, and consolidations.
Ansell Limited
Doug Tough Chief Executive Officer
Agenda
1. Background
2. Geographic & Business Portfolio
3. Strategic Focus
4. Results
FORWARD-LOOKING STATEMENTS
This presentation contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 as amended, and information that is based on managements beliefs as well as assumptions made by and information currently available to management. When used in this presentation, the words anticipate, approach, begin, believe, continue, expect, forecast, going forward, improved, likely, look forward, opportunity, outlook, plans, potential, proposal, should and would and similar expressions are intended to identify forward-looking statements. These forward-looking statements necessarily make assumptions, some of which are inherently subject to uncertainties and contingencies that are beyond the Companys control. Should one or more of these uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated or projected.
Background
Who is Ansell?
A 100 year old company
A world leader in healthcare barrier protection products and services
Ansell is an Australian listed Company (ASX: ANN) with ADSs on US (NASDAQ)
Market capitalization ~US$1.3 billion
Sales of ~US$800 million and over 11,000 employees
Statutory HQ in Australia, Operating HQ in the US, 85% of sales in Europe and N. America and most plants in Asia & Mexico.
Operating currency is the USD
Filings - Australian Statutory Report and SEC 20F
Corporate website www.ansell.com
Ratings Long Term Short Term Outlook
Standard & Poors BB+ B Stable
Moodys Ba1 Not Prime Stable
Life... is a risky business
Infections Contamination Viruses & Bacteria Toxins Injuries
4.7m work related injuries & illnesses in USA in 2002. Cost $170b
Over 2 million people get infections in US hospitals each year; costing $5b.
Only 25% of sexually active people use condoms. Lifetime medical cost burden of 9 million new cases of STDs in USA in 2000 estimated at over $6b.
Food-borne diseases from improper handling, processing and transport caused over 5000 deaths; $5b - $6b in medical costs and lost productivity in USA alone
What is the solution?
The first line of defense is protection A barrier as thin as .03 mm can save your life
This is our business
A Global Leader
Estimated global market size and positions
Surgical Gloves Occupational Gloves (Synthetics) Market: ~US$0.6B» Market: ~US$2.1B» 2004 2004 #2 Ansell ~ 23% #1 Ansell ~19%
Exam Gloves (Excluding Consumer (Condoms) Occupational) Market: ~US$0.9B» Market: ~US$1.0B» 2003 2003 #3 Ansell ~11% #2 Ansell ~ 11%
Source: Nielsen, IMS, and internal estimates
Key Customers
Companies: industrial, auto, chemicals, food etc.
Hospitals/Medical Centres
Retail: food stores, drug stores, convenience stores, mass merchandisers
F05 H1 Sales Analysis
Consumer Products (16%)
Professional Products (34%)
Occupational Products (50%)
Surgical Powdered 8%
Surgical Synthetic 2%
Surg Powder Free 9%
Synthetic Exam 4%
Powder Free Exam 8 %
PWD Exam 2%
Diasposal 10%
Knitted 6%
HyFlex 9%
General Purpose -Other 9%
Chemical Resistant 7%
Clothig & Other 5%
Household Gloves 4%
Household Gloves 3%
Bid Condoms 4%
Retail Condoms 9%
Manufacturing Facilities
India & Sri Lanka
Standard & Premium Surgical
Condoms
Powder Free Exam
General Purpose
Chemical Resistant
Critical Environment
Americas & UK
Chemical Resistant
General Purpose
Specialty
High spec knitted
Outsource US$75 M
Powdered Exam
Vinyl Exam
Low Volume Items
Employees (F05 H1)
84% in Asia
12% in Mexico
3% in North America
1% in Europe
Thailand
Condoms
Powder Free Exam
Household gloves
Synthetic Exam
Malaysia
Premium Surgical
Powder Free Exam
Powdered Exam
Household gloves
Ansell
Geographic and Business Portfolio
Ansell Regions F04
US$ M Americas Europe Asia Pac Total
Sales 387.0 285.2 119.7 791.9
% 49% 36% 15%
Segment EBITA 46.1 28.5 29.5 104.1
% 44% 27% 29%
Ansell Businesses F04
US$ M Occupational Professional Consumer Total
Sales 387.8 271.6 132.5 791.9
% 49% 34% 17%
Segment EBITA 52.8 28.7 22.6 104.1
% 51% 27% 22%
Occupational Business
US$ M F03 F04 F05 H1 H1 Movement
Sales 366.5 387.8 198.9 +9%
Segment EBITA 36.9 52.8 29.5 +30%
EBITA/Sales 10.1% 13.6% 14.8% +240 bp
Strategy: Continued concept of hand injury solutions Enhanced value added business model program Continued emphasis on superior products Continued emphasis on lower cost plants and outsourcing Expand ergonomic technology advantage across product categories
Professional Business
US$ M F03 F04 F05 H1 H1 Movement
Sales 265.5 271.6 134.2 +1%
Segment EBITA 31.6 28.7 15.4 +3%
EBITA/Sales 11.9% 10.6% 11.5% +20 bp
Strategy: Focused product improvements/upgrades US surgical market share recovery building off 6 GPO contracts Expand Synthetic range (surgical)
Consumer Business
US$ M F03 F04 F05 H1 H1 Movement
Sales 126.7 132.5 61.9 -7%
Segment EBITA 25.1 22.6 10.3 -17%
EBITA/Sales 19.8% 17.0% 16.6% - 190 bp
Strategy: Grow Branded Retail condom business Expand demand for unique foamlined household gloves leveraging FHP partner reach Use capacity through public sector and private label supply New product development; gloves, condoms, lubricants
Strategic Focus
Strategic Evolution
From meeting multi-year EBITA commitments to advancing Ansell Growth Strategy for F06 and Beyond
Methodology:
F04 Base
Organic Growth
Geographic Focus
Technology
Bolt on Acqisitions
Strategic Initiatives
Go Forward
Continue Track Record of Performance Delivery, Total Shareholder Return
Solidify New Senior Team Re Culture/Accountability Expectations
Deliver Base Growth Share/Value
Continue Occupational revitalisation
Restoration Plan for Professional/Consumer
Raise Team to Next Performance Level of Operational Excellence
Establish Platform for Future Growth among compelling opportunities
Organic
Geographical
External Numerous avenues
Results
Performance Trends
US$ M F03 F04 F05 H1 H1 Movement
Sales 758.7 791.9 395.0 +3%
Segment EBITA 93.6 104.1 55.2 +10%
Attributable Profits 29.3 50.4 31.7 +35%
Free Cash Flow 85.0 90.3 33.1 -15.0
EPS US$ 15.7¢ 27. 9¢ 18.1¢ +42%
Secure Earnings, Solid Growth
Delivering Total Shareholder Return
Track record of increasingly higher Profits and strong cash generation Dividends reintroduced for F03 and steadily increased EPS and ROE more than doubled in last two years
F03 TSR -11%
F04 TSR 34%
F05 H1 TSR 17%
10.5 10 9.5 9 8.5 8 7.5 7 6.5 6 5.5 5 4.5 4 3.5 3 2.5
1 July 02 31 Dec 02 30 June 03 31 Dec 03 30 June 04 31 Dec 04 28 Feb 05
10.5 10 9.5 9 8.5 8 7.5 7 6.5 6 5.5 5 4.5 4 3.5 3 2.5
YTD AUD +31%
AUD 7.70
YTD USD +48%
USD 5.38
$7.97
10.11
4,173
YTD ASX200+18% 3,534
Meeting Market Commitments
In 2002, we made a multi year Commitment to grow Segment EBITA 50% from F01 F05:
US$ Forecast Actual Growth
F02 >77 85 +10%
F03 >92 94 +11%
F04 >103 104 +11%
F05 115*
*Forecast Confirmed, Company on track to achieve US$115M Segment EBITA
Evolved to driving growth (organically and via acquisition) while maintaining Total Shareholder Return focus
ANSELL LIMITED
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ANSELL LIMITED (Registrant) | ||
By: | /s/ DAVID M. GRAHAM | |
Name: |
DAVID M. GRAHAM | |
Title: |
GENERAL MANAGER FINANCE & TREASURY |
Date: March 8, 2005